Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Prostatic Neoplasms × ipatasertib × 30 days × Clear all

Sponsor

Conditions

Neoplasm Metastasis 3 Ovarian Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Carcinoma 2 Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 27 Specimen Handling 26 enzalutamide 23 Prednisone 22 Abiraterone Acetate 19 apalutamide 17 Androgen Antagonists 17 darolutamide 13 Leuprolide 12 Radiotherapy 10 Pluvicto 10 Radiosurgery 9 Biopsy 9 cabazitaxel 8 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8 abiraterone 8 X-Rays 8 Goserelin 8 bicalutamide 7 Photons 7 Docetaxel 7 relugolix 6 prednylidene 6 luprolide acetate gel depot 6 gallium 68 PSMA-11 6 deltacortene 6 Triptorelin Pamoate 6 Gonadotropin-Releasing Hormone 6 Glutamate Carboxypeptidase II 6 Brachytherapy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡